Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis
- PMID: 32899059
- PMCID: PMC7478643
- DOI: 10.1097/MD.0000000000022033
Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis
Abstract
Background: In December 2019, the novel coronavirus pneumonia was detected in Wuhan and named COVID-19. It is an international outbreak of the respiratory illness caused by severe acute respiratory syndrome coronavirus 2. Recent papers pointed out the cytopenia in COVID-19 patients including lymphopenia, neutrophilia, thrombocytopenia and lower level of hemoglobin had prognostic significance. This systemic review and meta-analysis summaries the latest evidence from available data and determine the hematological abnormality caused by severe acute respiratory syndrome coronavirus 2 and potential efficacy on the outcomes in patients with COVID-19.
Methods: This protocol for a systematic reviews and meta-analysis will be performed according to the preferred reporting items for systematic reviews and meta-analysis protocols 2015 guidelines. The database of Cochrane Library, PUBMED, EMBASE, Medline, Web of Science, Google Scholar, CNKI, WanFang, as well as gray literatures from the inception to present will be comprehensively and systematically searched without limitations of regions or language. The main study outcomes will be the mortality of COVID-19 patients. The meta-analysis was performed by RevMan V.5.3 program and Stata V.12.0 software after 2 reviewers independently selected literature, data extraction, bias risk evaluation and study quality assessment. Any disagreement will be resolved by consensus to the third researcher.
Results: This systematic review and meta-analysis may help provide clarify on the effect of cytopenia in patients with COVID-19. The result will be published at a peer-reviewed journal.
Conclusions: This proposed study will evaluate the existing evidence on the effectiveness of cytopenia in COVID-19 patients.
Ethic and dissemination: The content of this article does not involve moral approval or ethical review because no individual data will be collected.
Prospero registration: CRD42020187524.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
COVID-19 in hematological malignancy patients: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Aug 28;99(35):e21376. doi: 10.1097/MD.0000000000021376. Medicine (Baltimore). 2020. PMID: 32871864 Free PMC article.
-
Effects of respiratory rehabilitation on patients with novel coronavirus (COVID-19) pneumonia in the rehabilitation phase: protocol for a systematic review and meta-analysis.BMJ Open. 2020 Jul 13;10(7):e039771. doi: 10.1136/bmjopen-2020-039771. BMJ Open. 2020. PMID: 32665352 Free PMC article.
-
Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): A protocol for systematic review and meta analysis.Medicine (Baltimore). 2020 Jul 17;99(29):e20781. doi: 10.1097/MD.0000000000020781. Medicine (Baltimore). 2020. PMID: 32702822 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
References
-
- Available at: https://coronavirus.jhu.edu/map.html accessed July 30, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources